KIM
HAE icon

Kestrel Investment Management’s Haemonetics HAE Stock Holding History

Kestrel Investment Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.3M Hold
97,400
– – 3.98% 5
2026
Q1 		$5.49M Sell
97,400
-700
-0.7% -$45.6K 3.28% 9
2025
Q4 		$7.86M Sell
98,100
-3,700
-4% -$249K 4.46% 4
2025
Q3 		$4.96M Buy
+101,800
New +$6.3M 2.8% 14
2016
Q2 		– Sell
-169,300
Closed -$5.92M – 43
2016
Q1 		$5.92M Sell
169,300
-2,700
-2% -$87.2K 2.28% 18
2015
Q4 		$5.54M Sell
172,000
-26,150
-13% -$848K 2.22% 23
2015
Q3 		$6.4M Sell
198,150
-2,500
-1% -$94.1K 2.23% 22
2015
Q2 		$8.3M Sell
200,650
-197,000
-50% -$8.3M 2.56% 19
2015
Q1 		$17.9M Sell
397,650
-12,000
-3% -$502K 2.44% 18
2014
Q4 		$15.3M Sell
409,650
-8,900
-2% -$326K 2.04% 20
2014
Q3 		$14.6M Sell
418,550
-14,500
-3% -$517K 2.07% 17
2014
Q2 		$15.3M Sell
433,050
-8,200
-2% -$274K 1.9% 22
2014
Q1 		$14.4M Sell
441,250
-11,150
-2% -$426K 1.78% 23
2013
Q4 		$19.1M Sell
452,400
-96,800
-18% -$3.98M 2.34% 17
2013
Q3 		$21.9M Sell
549,200
-10,100
-2% -$424K 2.25% 19
2013
Q2 		$23.1M Buy
+559,300
New +$22.6M 2.56% 14

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kestrel Investment Management's HAE Position: Q2 2026 in Review

Kestrel Investment Management held its Haemonetics (HAE) position steady in Q2 2026 at 97,400 shares worth $7.3M. The position accounts for 3.98% of the portfolio, ranked #5.

Kestrel Investment Management first reported a position in HAE in Q2 2013 and has held it in 16 quarters since. The position peaked at $23.1M in Q2 2013. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Kestrel Investment Management held 97,400 shares of Haemonetics worth $7.3M as of Q2 2026.
  • Kestrel Investment Management left its Haemonetics share count unchanged in Q2 2026.
  • Haemonetics made up 3.98% of Kestrel Investment Management's portfolio in Q2 2026, its #5 holding.
  • Kestrel Investment Management first reported a position in Haemonetics in Q2 2013 and has held it in 16 quarters since.
  • Kestrel Investment Management's Haemonetics position peaked at $23.1M in Q2 2013.
  • 330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Kestrel Investment Management's 13F filing for Q2 2026, filed 4 Aug 2026.